Heat Biologics reports plans to price public sale of its common stock

Aegis Capital is bookrunning manager; H.C. Wainwright is lead manager

By Devika Patel

Knoxville, Tenn., March 10 – Heat Biologics, Inc. said it will conduct a public offering of common stock.

Aegis Capital Corp. is the bookrunner, and H.C. Wainwright & Co., LLC is the lead manager.

Proceeds will be used for general corporate purposes.

The biopharmaceutical company is based in Durham, N.C.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.